首页> 美国卫生研究院文献>Diabetes Care >Efficacy and Safety of Taspoglutide Monotherapy in Drug-Naive Type 2 Diabetic Patients After 24 Weeks of Treatment

【2h】

Efficacy and Safety of Taspoglutide Monotherapy in Drug-Naive Type 2 Diabetic Patients After 24 Weeks of Treatment

机译：Taspoglutide单药治疗24周后未接受过药物治疗的2型糖尿病患者的疗效和安全性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

OBJECTIVETo evaluate the efficacy and safety of taspoglutide monotherapy in drug-naive patients with type 2 diabetes inadequately controlled.

机译：目的评估他喷鲁肽单药治疗在药物控制不充分的未接受过药物治疗的2型糖尿病患者中的疗效和安全性。

著录项

期刊名称 Diabetes Care
作者
Itamar Raz; Vivian Fonseca; Mark Kipnes; Laurence Durrwell; John Hoekstra; Mark Boldrin; Raffaella Balena;
展开▼
作者单位

展开▼
年(卷),期 2012(35),3
年度 2012
页码 485–487
总页数 3
原文格式 PDF
正文语种
中图分类护理学 ;
关键词

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of taspoglutide monotherapy in drug-naive type 2 diabetic patients after 24 weeks of treatment: Results of a randomized, double-blind, placebo-controlled phase 3 study (T-emerge 1) [J] . RazI., HoekstraJ., FonsecaV., Diabetes care . 2012 ,第3期

机译：Taspoglutide单药治疗24周后未接受过药物治疗的2型糖尿病患者的疗效和安全性：一项随机，双盲，安慰剂对照的3期研究的结果（T出现1）
2. Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study. [J] . Moretto TJ, Milton DR, Ridge TD, Clinical therapeutics . 2008 ,第8期

机译：艾塞那肽单药治疗24天抗糖尿病药物未治疗患者的疗效和耐受性：一项随机，双盲，安慰剂对照，平行组研究。
3. Efficacy and Safety of Taspoglutide in Patients with Type 2 Diabetes Inadequately Controlled with Metformin Plus Pioglitazone over 24 Weeks: T-Emerge 3 Trial [J] . Robert R. Henry, Sunder Mudaliar, Linda Kanitra, The journal of clinical endocrinology and metabolism . 2012 ,第7期

机译：Taspoglutide在2型糖尿病患者中的疗效和安全性与二甲双胍加上吡格列酮在24周内患者不足：T-Emerge 3试验
4. IMANI-1 TC3WP Single Drug HAART -Proof of Concept Study Pilot Study of the Safety and Efficacy of Kaletra (LPV/r) as Single Drug HAART in HIV+ ARV- Naive Patients - Interim Analysis of Subjects Completing Final 48 Week Data [C] . J.C. Gathe Jr., M. Washington, C. Mayberry International AIDS Conference . 2004

机译：Imani-1 TC3WP单药搭载概念研究试验试验研究Kaletra（LPV / R）作为艾滋病毒+ ARV天真患者单药HAART的安全性和有效性 - 临时分析受试者完成最终的48周数据
5. Anti-diabetic treatment and cancer occurrence among patients with type II diabetes mellitus. [D] . Qiu, Hong. 2011

机译：II型糖尿病患者的抗糖尿病治疗和癌症发生。
6. Efficacy and safety of linagliptin monotherapy in Asian patients with inadequately controlled type 2 diabetes mellitus: A multinational 24-week randomized clinical trial [O] . Yuhong Chen, Guang Ning, Changjiang Wang, 2015

机译：利格列汀单药治疗在2型糖尿病控制不足的亚洲患者中的疗效和安全性：一项多国24周随机临床试验
7. Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26-week double-blind study. [O] . Russell-Jones, D, Cuddihy, RM, Hanefeld, M, 2012

机译：艾塞那肽每周两次与二甲双胍，吡格列酮和西他列汀作为单药治疗未使用过药物的2型糖尿病患者的疗效和安全性（DURATION-4）：一项为期26周的双盲研究。

Efficacy and Safety of Taspoglutide Monotherapy in Drug-Naive Type 2 Diabetic Patients After 24 Weeks of Treatment

摘要

著录项

相似文献

相关主题

期刊订阅